Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study
Sponsor: University of Colorado, Denver
Terminated
Loss of funding
Other terminated trials from University of Colorado, Denver
Other Alzheimer Disease trials with similar outcome
This observational or N/A phase trial investigates Alzheimer Disease and Down Syndrome and is currently terminated or withdrawn. University of Colorado, Denver leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
17 versions recorded-
Jun 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Feb 2024 — May 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 12 earlier versions
-
Dec 2021 — Feb 2024 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
-
Jan 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .